ORSENIX
Orsenix is a clinical-stage biotech company developing a novel oral form of arsenic trioxide (ATO) to treat acute promyelocytic leukemia (APL) and other cancers. It is committed to transforming cancer treatment with innovative oral therapies that give patients the freedom to live their everyday lives.
ORSENIX
Industry:
Biotechnology Life Science Medical
Address:
Wilmington, Delaware, United States
Country:
United States
Status:
Active
More informations about "Orsenix"
Orsenix - Products, Competitors, Financials, Employees, …
In addition, Orsenix is eligible to receive a $6 million regulatory milestone related to the development of SY-2101 in APL and commercial milestones of up to $10 million. Orsenix is …See details»
Orsenix (SY-2101) 2025 Company Profile: Valuation, Investors ...
Orsenix (SY-2101) General Information Description. Portfolio of Intellectual property, clinical and preclinical data, the regulatory dossier and product inventory related to the development and …See details»
Orsenix Company Profile - Office Locations, Competitors ... - Craft
Orsenix is a clinical-stage biotech company focusing on oral therapies to treat cancer. It develops a capsule form of arsenic trioxide for acute promyelocytic leukemia and other cancers. Type …See details»
Orsenix - 2025 Company Profile & Competitors - Tracxn
Orsenix is a deadpooled company based in Wilmington (United States), founded in 2014. It operates as a Developer of therapeutics for the treatment of cancer. The company has 3012 …See details»
Orsenix LLC - Drug pipelines, Patents, Clinical trials - Synapse
Explore Orsenix LLC with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news, Drug:Arsenic Trioxide.See details»
Orsenix - Updates, News, Events, Signals & Triggers - Crunchbase
Orsenix is a clinical stage biotech company developing a novel oral form of arsenic trioxide.See details»
Syros Pharmaceuticals acquires Orsenix - 2020-12-07 - Crunchbase
Dec 7, 2020 Orsenix Orsenix is a clinical stage biotech company developing a novel oral form of arsenic trioxide. Acquiring Organization: Syros Pharmaceuticals Syros Pharmaceuticals is a …See details»
Orsenix - VentureRadar
Orsenix VentureRadar profile. Find out more about Orsenix, Small Molecule Pharmaceuticals.See details»
Orsenix | Company Profile | Pharmacompass.com
Company Profile of OrsenixSee details»
Syros acquires Orsenix’s SY-2102 drug candidate for APL treatment
Dec 9, 2020 In recent developments, Syros Pharmaceuticals, Inc, a Cambridge-headquartered biopharmaceutical organization that focuses on developing treatments for immune-related …See details»
Orsenix - The Pharmaletter
Orsenix "Orsenix is a clinical stage biotech company developing a novel oral form of arsenic trioxide (ATO) to treat acute promyelocytic leukemia (APL) and other cancers." ...See details»
Orsenix LLC - BioCentury Company Profiles - BCIQ
Orsenix LLC - BioCentury Company Profiles for the biopharma industrySee details»
Syros Acquires Clinical Candidate for the Treatment of Rare Blood ...
Dec 7, 2020 Syros Pharmaceuticals has acquired Orsenix’ ORH-2014, a targeted clinical-stage drug candidate that has the potential to dramatically reduce the treatment burden of a …See details»
Syros acquires clinical-stage drug candidate for acute …
Orsenix is also eligible to receive single-digit million milestone payments related to the development of SY-2101 in indications other than APL. About Acute Promyelocytic Leukemia. …See details»
Arsenic trioxide oral - Syros Pharmaceuticals - AdisInsight
Arsenic trioxide (also known as SY 2101) was an apoptosis stimulant, originated by Orsenix Holdings BV and was being developed by Syros Pharmaceuticals for the Arsenic trioxide oral - …See details»
Sirish Nidamarthy, MSc., M.S., MBA - CPL - LinkedIn
Director Of Operations at Orsenix LLC · Experienced pharmaceutical professional. Managed and led project teams cross-functionally in drug discovery and development organizations. …See details»
Dangerously high levels of arsenic and cadmium found in store …
1 day ago The organization, which is dedicated to reducing children’s exposure to toxic chemicals, produced the report. Related article A spokesperson for Consumer Reports …See details»
First on CNN: Dangerously high levels of arsenic and cadmium
The organization, which is dedicated to reducing children’s exposure to toxic chemicals, produced the report. “Heavy metal contamination in young children is especially concerning, as early ...See details»
Store-bought rice contains high levels of arsenic - WISH-TV
1 day ago The organization, which is dedicated to reducing children’s exposure to toxic chemicals, produced the report. “Heavy metal contamination in young children is especially …See details»
High levels of arsenic and cadmium found in rice sold in ... - CBS …
20 hours ago The report, which comes from Healthy Babies, Bright Futures, an organization focused on babies' exposure to toxic chemicals, found arsenic in 100% of rice samples …See details»